Lisinopril And Hydrochlorothiazide
Product Images NDC 53002-1674

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 53002-1674). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (3a53f18e Af9b 4932 8300 B3521e87528d 01)

Chemical structure diagram of lisinopril dihydrate, the active ingredient in the product Lisinopril and Hydrochlorothiazide by RPK Pharmaceuticals, Inc. The diagram shows the molecule's atomic connectivity and arrangement, including its dihydrate form.*

FDA Label Image

Figure 2 (3a53f18e Af9b 4932 8300 B3521e87528d 02)

Chemical structure diagram of Hydrochlorothiazide, one of the active ingredients in Lisinopril and Hydrochlorothiazide by RPK Pharmaceuticals, Inc. The structure shows a chlorinated benzene ring with sulfonamide groups attached.*

FDA Label Image

Label Image (Lbl530021674)

Label for Lisinopril and Hydrochlorothiazide 20-12.5 mg tablets by RPK Pharmaceuticals, Inc. The label indicates 100 tablets in the bottle, with directions to take one tablet daily or as directed by a healthcare provider. It includes space for patient and prescription details and has multiple barcode areas.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.